Jun 30, 2016

ANI Pharmaceuticals Q2 2016 Earnings Report

Total Revenue
$31.3M
Previous year: $19.5M
+60.5%
EPS
$1.11
Previous year: $0.55
+101.8%
Gross Profit
$19.5M
Previous year: $16.4M
+19.3%
Cash and Equivalents
$15M
Previous year: $167M
-91.0%
Free Cash Flow
$2.62M
Previous year: $1.01M
+159.7%
Total Assets
$308M
Previous year: $270M
+14.0%

ANI Pharmaceuticals

ANI Pharmaceuticals